The current GMAB market cap is 16.02B. The company's latest EPS is DKK 11.8512 and P/E is 20.25.
Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
Total Revenue | 10.11B | 8.48B | 14.6B | 16.47B | 21.53B |
Operating Income | 6.31B | 3.02B | 6.36B | 5.32B | 6.7B |
Net Income | 4.76B | 3.01B | 5.52B | 4.35B | 7.84B |
Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
Total Assets | 21.14B | 24.63B | 30.28B | 35.29B | 45.81B |
Total Liabilities | 2.02B | 2.43B | 2.84B | 3.68B | 9.11B |
Total Equity | 19.12B | 22.2B | 27.44B | 31.61B | 36.7B |
Market Cap | 16.02B |
Price to Earnings Ratio | 20.25 |
Price to Sales Ratio | 7.38 |
Price to Cash Ratio | 16.11 |
Price to Book Ratio | 4.33 |
Dividend Yield | - |
Shares Outstanding | 661.87M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 1.25 (5.09%) |
Company Name | Genmab AS |
Address |
kalvebod brygge 43 copenhagen 1260 |
Website | https://www.genmab.com |
Industry | biogenetic (human) (H4) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions